Psoriatic Arthritis

Patients With Psoriatic Arthritis, Psoriasis Often Face Psychosocial Challenges

Researchers examined the range of patient experiences with psoriasis and psoriatic arthritis to inform gaps in patient-centered care.

No Differences in Incident AF and MACE Risk With Ustekinumab vs TNFi in PsA, Psoriasis

Investigators assessed the risk for atrial fibrillation and major adverse cardiovascular events potentially related to using ustekinumab vs tumor necrosis factor inhibitors in patients with psoriasis or psoriatic arthritis.

Cardiovascular-Related Risk Factors Evaluated in Psoriatic Arthritis

A high prevalence of CVD-related risk factors was observed in a cohort of patients with psoriatic arthritis.

Factors Associated With Patient-Physician Discordance in Psoriatic Arthritis Examined

Researchers examined factors associated with patient‐physician discordance in a cohort of patients with psoriatic arthritis.

Serum-Based Soluble Biomarkers Differentially Expressed in Psoriatic Arthritis, Osteoarthritis

Researchers identified a panel of 4 biomarkers that provide additional discriminatory value to that provided by age and sex alone in distinguishing psoriatic arthritis from osteoarthritis.

Ultrasound vs Clinical Assessment of Peripheral Enthesitis in PsA and Fibromyalgia

Researchers evaluated the prevalence of clinical and ultrasonographic entheseal involvement in patients with psoriatic arthritis, psoriasis, and fibromyalgia.

Herpes Zoster Risk and Vaccination Recommendations in Psoriatic Arthritis

Investigators assessed the risk for herpes zoster and provided recommendations regarding treatment in patients with psoriasis.

Pro-Inflammatory Dietary Pattern Not a Risk Factor for Psoriasis, PsA, or AD

Data from the Nurses’ Health Study II were used to assess the relationship between pro-inflammatory diet and psoriasis, psoriatic arthritis, and atopic dermatitis.

Dactylitis, Enthesitis Resolution With Biologic Medications in Psoriatic Arthritis

Anti-TNF-α agents have the same efficacy as ustekinumab, secukinumab, and ixekizumab in terms of dactylitis and enthesitis resolution.

Baseline C-Reactive Protein Levels Linked to Structural Progression in PsA

Elevated C-reactive protein levels at baseline were associated with greater structural progression in psoriatic arthritis.